(Q47958506)

English

Rivastigmine in apathetic but dementia and depression-free patients with Parkinson's disease: a double-blind, placebo-controlled, randomised clinical trial

scientific article published on 11 November 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/24218528

Rivastigmine in apathetic but dementia and depression-free patients with Parkinson's disease: a double-blind, placebo-controlled, randomised clinical trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/24218528

0 references

1 reference

based on heuristic

inferred from title

Parkinson's disease

1 reference

based on heuristic

inferred from title

1

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/24218528

Romain Lefaucheur

4

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/24218528

Jean-Philippe Azulay

9

object named as

Jean-Philippe Azulay

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

16

object named as

Luc Defebvre

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

author name string

Caroline Moreau

2

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/24218528

David Maltête

3

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/24218528

Alexandre Kreisler

5

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/24218528

Alexandre Eusebio

6

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/24218528

Gilles Defer

7

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/24218528

Thavarak Ouk

8

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/24218528

Pierre Krystkowiak

10

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/24218528

Tatiana Witjas

11

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/24218528

Marie Delliaux

12

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/24218528

Alain Destée

13

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/24218528

Alain Duhamel

14

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/24218528

Régis Bordet

15

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/24218528

Kathy Dujardin

17

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/24218528

language of work or name

0 references

publication date

11 November 2013

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/24218528

Journal of Neurology, Neurosurgery and Psychiatry

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/24218528

85

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/24218528

6

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/24218528

668-674

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/24218528

Apathy: a neuropsychiatric syndrome

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306439

21 January 2018

Neuropsychiatric symptoms in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306439

21 January 2018

Characteristics of apathy in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306439

21 January 2018

Dopamine, learning and motivation

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306439

21 January 2018

Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306439

21 January 2018

Apathy following subthalamic stimulation in Parkinson disease: a dopamine responsive symptom

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306439

21 January 2018

Parkinsonian apathy responds to dopaminergic stimulation of D2/D3 receptors with piribedil

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306439

21 January 2018

Subthalamic nucleus stimulation in Parkinson disease induces apathy: a PET study

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306439

21 January 2018

Apathy may herald cognitive decline and dementia in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306439

21 January 2018

Cognitive and behavioral dysfunction in Parkinson's disease: neurochemical and clinicopathological contributions

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306439

21 January 2018

The cholinergic hypothesis of neuropsychiatric symptoms in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306439

21 January 2018

Toward a molecular neuropsychiatry of neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306439

21 January 2018

Rivastigmine for dementia associated with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306439

21 January 2018

The Lille apathy rating scale (LARS), a new instrument for detecting and quantifying apathy: validation in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306439

21 January 2018

Apathy and anhedonia rating scales in Parkinson's disease: critique and recommendations

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306439

21 January 2018

The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306439

21 January 2018

Proposed diagnostic criteria for apathy in Alzheimer's disease and other neuropsychiatric disorders.

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306439

21 January 2018

Clinical diagnostic criteria for dementia associated with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306439

21 January 2018

The Parkinson's Disease Questionnaire (PDQ-39): development and validation of a Parkinson's disease summary index score.

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306439

21 January 2018

Influential Observations in Linear Regression

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306439

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306439

21 January 2018

Methylphenidate for gait hypokinesia and freezing in patients with Parkinson's disease undergoing subthalamic stimulation: a multicentre, parallel, randomised, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306439

21 January 2018

Apathy in Parkinson's disease: diagnostic and etiological dilemmas

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306439

21 January 2018

IDEAL: a 6-month, double-blind, placebo-controlled study of the first skin patch for Alzheimer disease

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306439

21 January 2018

Utility of the Mattis dementia rating scale to assess the efficacy of rivastigmine in dementia associated with Parkinson’s disease

1 reference

https://api.crossref.org/works/10.1136%2FJNNP-2013-306439

21 January 2018

Identifiers

10.1136/JNNP-2013-306439

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/24218528

release_iwul7zm7grd4ncixxrknznnhd4

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 February 2018

http://europepmc.org/abstract/MED/24218528

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q47958506&oldid=2177137451"